162 related articles for article (PubMed ID: 37005673)
1. Label extension, single-arm, phase III study shows efficacy and safety of stempeucel® in patients with critical limb ischemia due to atherosclerotic peripheral arterial disease.
Gupta PK; Shivashankar P; Rajkumar M; Mahapatra SS; Desai SC; Dhar A; Krishna V; Raviraja NS; Bhat S; Viswanathan P; Kannan S; Abraham J; Boggarapu H; Manjuprasad MS; Udaykumar K
Stem Cell Res Ther; 2023 Apr; 14(1):60. PubMed ID: 37005673
[TBL] [Abstract][Full Text] [Related]
2. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK; Dutta S; Kala S; Nekkanti M; Desai SC; Mahapatra SS; Dhar A; Raju R; M R; Behera A; P S; Raviraja NS; Viswanathan P; Chandrashekar M; Thej C; K V P; Abraham J; Boggarapu H; Udaykumar K
Stem Cells Transl Med; 2021 Dec; 10(12):1602-1613. PubMed ID: 34519179
[TBL] [Abstract][Full Text] [Related]
3. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
4. Lumbar sympathectomy versus prostanoids for critical limb ischaemia due to non-reconstructable peripheral arterial disease.
Sen I; Agarwal S; Tharyan P; Forster R
Cochrane Database Syst Rev; 2018 Apr; 4(4):CD009366. PubMed ID: 29658630
[TBL] [Abstract][Full Text] [Related]
5. A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia.
Gupta PK; Chullikana A; Parakh R; Desai S; Das A; Gottipamula S; Krishnamurthy S; Anthony N; Pherwani A; Majumdar AS
J Transl Med; 2013 Jun; 11():143. PubMed ID: 23758736
[TBL] [Abstract][Full Text] [Related]
6. Autologous cells derived from different sources and administered using different regimens for 'no-option' critical lower limb ischaemia patients.
Abdul Wahid SF; Ismail NA; Wan Jamaludin WF; Muhamad NA; Abdul Hamid MKA; Harunarashid H; Lai NM
Cochrane Database Syst Rev; 2018 Aug; 8(8):CD010747. PubMed ID: 30155883
[TBL] [Abstract][Full Text] [Related]
7. Stenting for peripheral artery disease of the lower extremities: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2010; 10(18):1-88. PubMed ID: 23074395
[TBL] [Abstract][Full Text] [Related]
8. Report of a phase 1 clinical trial for safety assessment of human placental mesenchymal stem cells therapy in patients with critical limb ischemia (CLI).
Shirbaghaee Z; Heidari Keshel S; Rasouli M; Valizadeh M; Hashemi Nazari SS; Hassani M; Soleimani M
Stem Cell Res Ther; 2023 Jul; 14(1):174. PubMed ID: 37408043
[TBL] [Abstract][Full Text] [Related]
9. Rationale and design of the MarrowStim PAD Kit for the Treatment of Critical Limb Ischemia in Subjects with Severe Peripheral Arterial Disease (MOBILE) trial investigating autologous bone marrow cell therapy for critical limb ischemia.
Wang SK; Green LA; Motaganahalli RL; Wilson MG; Fajardo A; Murphy MP
J Vasc Surg; 2017 Jun; 65(6):1850-1857.e2. PubMed ID: 28390770
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcome after intramuscular transplantation of granulocyte colony stimulating factor-mobilized CD34 positive cells in patients with critical limb ischemia.
Kinoshita M; Fujita Y; Katayama M; Baba R; Shibakawa M; Yoshikawa K; Katakami N; Furukawa Y; Tsukie T; Nagano T; Kurimoto Y; Yamasaki K; Handa N; Okada Y; Kuronaka K; Nagata Y; Matsubara Y; Fukushima M; Asahara T; Kawamoto A
Atherosclerosis; 2012 Oct; 224(2):440-5. PubMed ID: 22877866
[TBL] [Abstract][Full Text] [Related]
11. PACE: randomized, controlled, multicentre, multinational, phase III study of PLX-PAD for critical limb ischaemia in patients unsuitable for revascularization: randomized clinical trial.
Norgren L; Weiss N; Nikol S; Lantis JC; Patel MR; Hinchliffe RJ; Reinecke H; Volk HD; Reinke P; Fadini GP; Ofir R; Rothenstein D; Halevy N; Karagjozov M; Rundback JH
Br J Surg; 2024 Jan; 111(2):. PubMed ID: 38294084
[TBL] [Abstract][Full Text] [Related]
12. Randomized, Double-Blind, Placebo-Controlled Trial to Evaluate Safety and Therapeutic Efficacy of Angiogenesis Induced by Intraarterial Autologous Bone Marrow-Derived Stem Cells in Patients with Severe Peripheral Arterial Disease.
Sharma S; Pandey NN; Sinha M; Kumar S; Jagia P; Gulati GS; Gond K; Mohanty S; Bhargava B
J Vasc Interv Radiol; 2021 Feb; 32(2):157-163. PubMed ID: 33248918
[TBL] [Abstract][Full Text] [Related]
13. Human bone marrow-derived, pooled, allogeneic mesenchymal stromal cells manufactured from multiple donors at different times show comparable biological functions in vitro, and in vivo to repair limb ischemia.
Thej C; Balasubramanian S; Rengasamy M; Walvekar A; Swamynathan P; Raj SS; Shahani P; Siddikuzzaman ; Kolkundkar U; Seetharam RN; Gupta PK; Majumdar AS
Stem Cell Res Ther; 2021 May; 12(1):279. PubMed ID: 33971964
[TBL] [Abstract][Full Text] [Related]
14. Autologous bone-marrow mononuclear cell implantation reduces long-term major amputation risk in patients with critical limb ischemia: a comparison of atherosclerotic peripheral arterial disease and Buerger disease.
Idei N; Soga J; Hata T; Fujii Y; Fujimura N; Mikami S; Maruhashi T; Nishioka K; Hidaka T; Kihara Y; Chowdhury M; Noma K; Taguchi A; Chayama K; Sueda T; Higashi Y
Circ Cardiovasc Interv; 2011 Feb; 4(1):15-25. PubMed ID: 21205941
[TBL] [Abstract][Full Text] [Related]
15. Phase I trial: the use of autologous cultured adipose-derived stroma/stem cells to treat patients with non-revascularizable critical limb ischemia.
Bura A; Planat-Benard V; Bourin P; Silvestre JS; Gross F; Grolleau JL; Saint-Lebese B; Peyrafitte JA; Fleury S; Gadelorge M; Taurand M; Dupuis-Coronas S; Leobon B; Casteilla L
Cytotherapy; 2014 Feb; 16(2):245-57. PubMed ID: 24438903
[TBL] [Abstract][Full Text] [Related]
16. Midterm Outcomes From a Pilot Study of Percutaneous Deep Vein Arterialization for the Treatment of No-Option Critical Limb Ischemia.
Kum S; Tan YK; Schreve MA; Ferraresi R; Varcoe RL; Schmidt A; Scheinert D; Mustapha JA; Lim DM; Ho D; Tang TY; Alexandrescu VA; Mutirangura P
J Endovasc Ther; 2017 Oct; 24(5):619-626. PubMed ID: 28697694
[TBL] [Abstract][Full Text] [Related]
17. Safety and Efficacy of Repeated Bone Marrow Mononuclear Cell Therapy in Patients with Critical Limb Ischemia in a Pilot Randomized Controlled Trial.
Molavi B; Zafarghandi MR; Aminizadeh E; Hosseini SE; Mirzayi H; Arab L; Baharvand H; Aghdami N
Arch Iran Med; 2016 Jun; 19(6):388-96. PubMed ID: 27293053
[TBL] [Abstract][Full Text] [Related]
18. Drug-eluting balloon angioplasty versus uncoated balloon angioplasty for peripheral arterial disease of the lower limbs.
Kayssi A; Al-Atassi T; Oreopoulos G; Roche-Nagle G; Tan KT; Rajan DK
Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD011319. PubMed ID: 27490003
[TBL] [Abstract][Full Text] [Related]
19. Clinical Safety and Preliminary Efficacy of Plasmid pUDK-HGF Expressing Human Hepatocyte Growth Factor (HGF) in Patients with Critical Limb Ischemia.
Cui S; Guo L; Li X; Gu Y; Fu J; Dong L; Song H; Chen X; Lu Y; Hu C; Xiao F; Zhu D; Wu Z; Zhang Q
Eur J Vasc Endovasc Surg; 2015 Oct; 50(4):494-501. PubMed ID: 26122834
[TBL] [Abstract][Full Text] [Related]
20. Prevalence and severity of peripheral arterial disease among patient with heel pressure ulcer: a retrospective study of 42 patients.
Tisserand G; Zenati N; Seinturier C; Blaise S; Pernod G
Geriatr Psychol Neuropsychiatr Vieil; 2017 Sep; 15(3):242-246. PubMed ID: 28872035
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
